Should You Be Investing In Marijuana

Matt Thalman - INO.com Contributor - ETFs


In April the world's first Marijuana Exchange Traded Fund, Horizon Medical Marijuana Life Sciences ETF (TSE:HMMJ) hit the public markets. The ETF went public at $10 per share and popped during its first few days of trading.

When HMMJ hit the public markets, investors were craving exposure to marijuana stocks as new laws and regulations have helped push marijuana into the mainstream spotlight. Some U.S. states and parts of Canada have decriminalized the drug while it has spread in popularity and acceptance for its medical use.

HMMJ

HMMJ has traded as high as $23 per share since going public, but currently, it is below its Initial Public Offering price, trading at $9.36 per share. So what is happening and is it worth investing in the industry today? Continue reading "Should You Be Investing In Marijuana"

Market Mixed As It Wraps Up A Solid Quarter Of Gains

Hello traders everywhere. As we come to the end of the third quarter in 2017, let's take a look at where the markets stand heading into the fourth quarter.

The S&P 500 is on pace for quarterly gains of nearly 4% percent and its eighth straight quarter of gains dating back to October of 2015.

The DOW is on track for a third straight quarter of gains standing at 4.8%; this is its eighth straight quarter of gains. That's the first time it's happened since 1997.

MarketClub's Mid-day Market Report

The NASDAQ composite is on it's way to quarterly gains of almost 6%, its fifth consecutive positive quarter since 2015.

Even with the recent gains over the last few days, the U.S. Dollar continues to weaken losing a little over 2% in the quarter.

Crude Oil is looking to close out the third quarter of 2017 with a stellar gain of 10% effectively wiping out the 10% loss in the second quarter of this year.

Gold is posting a quarterly gain of almost 3% following a modest loss of .8% last quarter.

Key levels to watch next week: Continue reading "Market Mixed As It Wraps Up A Solid Quarter Of Gains"

CFPB Stays, But Cordray Goes

George Yacik - INO.com Contributor - Fed & Interest Rates


The worst-kept secret in Washington is that Consumer Financial Protection Bureau Director Richard Cordray may be running for governor of Ohio. Whether that satisfies his political ambitions or not is unclear, given that if he wins he would have to answer to someone other than himself – the state’s taxpayers – a position he doesn’t seem comfortable with.

In a country loaded with way too many arrogant politicians and government officials who think they are above the law and normal standards of decency, Cordray has set the bar pretty low. Few public officials have shown the level of contempt for legitimate questioning from Congress, the White House and the industries his agency oversees than Cordray has shown since he took over the CFPB, and it’s only gotten worse in the past few months as his tenure winds down.

More seriously, his obstinacy, haughtiness, and lack of candor are likely to cost the agency a lot of goodwill and support in Washington, and possibly among the public. He owes it to the agency he helped build and supposedly loves to step down immediately before he creates more damage.

Now comes word that Cordray’s agency may have botched the Wells Fargo scandal – big time. Not only has there been previous evidence that the CFPB was lackadaisical in investigating the bank’s sales practices, at least a year after the Los Angeles Times reported there were problems, but now a recently released internal memo shows that the agency’s lawyers felt there was a strong justification to hit the bank with a $10 billion penalty, instead of settling for a paltry $100 million last September.

What’s up with that? Continue reading "CFPB Stays, But Cordray Goes"

Yellen States Gradual Hikes Should Continue

Hello Traders everywhere. The U.S. dollar rose to a one-month high as Republicans rolled out their U.S. tax reform plan and after Yellen's speech on Tuesday.

Despite slowing inflation, Fed Chair Janet Yellen stated on Tuesday that she believes that the Federal Reserve needs to continue gradual rate hikes. Yellen delivered a speech in Cleveland to the National Association for Business Economics on Tuesday in which she stated, "that the Fed may have "misspecified" its models for inflation, and "misjudged" key facts like the underlying strength of the labor market and whether inflation expectations are as stable as they seem, and central bankers need to remain open to that possibility as they decide on policy".

Still, recent low inflation was likely a reflection of factors that would fade over time and despite uncertainties, it "would be imprudent to keep monetary policy on hold until inflation is back to 2%."

"Without further modest increases in the federal fund's rate over time, there is a risk that the labor market could eventually become overheated, potentially creating an inflationary problem down the road that might be difficult to overcome without triggering a recession," she said.

MarketClub's Mid-day Market Report

Key levels to watch this week: Continue reading "Yellen States Gradual Hikes Should Continue"

3 Cannabis Stocks Profiting from Germany's New Medical Program

Analysis originally distributed on September 20, 2017 By: Michael Vodicka of Cannabis Stock Trades

Germany is quickly beginning to look like the next mega market for medical and eventually recreational cannabis. This is creating another big opportunity for savvy investors who are following the story and staying ahead of the curve.

Today, I am going to show you how you can profit.

But first - a little background.

Germany is the beating heart of Europe.

It is the largest country in the European Union with a population of 81 million.

It also has the largest economy in the European Union by a long shot. Its gross domestic product clocked in at $3.5 billion in 2016. Its per capita GDP of $42,000 makes it one of the wealthiest countries in Europe.

Companies that can gain access to the German consumer market have an opportunity to access tens of millions of wealthy consumers.

This is particularly true in Germany's young medical cannabis market. Continue reading "3 Cannabis Stocks Profiting from Germany's New Medical Program"